A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

Completed · Phase 1

Conditions studied: Alzheimer's Disease

In brief

A study to assess the effect of heat application on the delivery profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

Key facts

Study ID

NCT03438604

Run by

Corium, Inc.

People needed

24

Starts

2018-02-13

Expected to finish

2018-06-30

Last updated by the study team

2018-09-14

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy, adult, male or female ≥ 30 years of age

You may not qualify if…

• History of any illness that, in the opinion of the investigator, might confound the results of the study or poses an additional risk to the subject by participation in the study
• History or presence of alcoholism or drug abuse within the past 2 years prior to the first study product treatment
• History or presence of hypersensitivity or idiosyncratic reaction to the study products or related compounds
• History of significant multiple and/or severe allergies, or has had an anaphylactic reaction or significant intolerability to prescription or nonprescription drugs
• History or presence of excessive sweating
• History or presence of hairy skin on application sites
• History or presence of significant skin damage or disease at application sites
• Any medical or surgical procedure or trauma within 28 days prior to the first study product treatment

Where it is running

• Celerion — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.